Saudi Arabia Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2024-2032

Saudi Arabia Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A16871
Buy Now

Market Overview:

The Saudi Arabia vaccine market size is projected to exhibit a growth rate (CAGR) of 2.94% during 2024-2032. The implementation of various policies and initiatives by the Saudi government, increasing awareness about the importance of vaccines, rapid technological advancements in vaccine development, and heightened popularity of e-health services and mobile applications represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 2.94%


Vaccines refer to biological preparations that provide active acquired immunity to particular infectious diseases. They are manufactured from the weakened or killed forms of the microbe, its surface proteins, or toxins. Vaccines are available in multiple types, such as live attenuated, inactivated, subunit, toxoid, conjugate, deoxyribonucleic acid (DNA), and recombinant vector vaccines. They are formulated to be immunogenic and non-pathogenic and contain various preservatives, stabilizers, and adjuvants to enhance their efficacy. Vaccines are utilized in multiple applications, including the prevention of diseases, such as measles, influenza, hepatitis, polio, tetanus, diphtheria, pertussis, coronavirus (COVID-19), and human papillomavirus (HPV). They aid in preventing deaths, supporting the eradication of diseases, reducing the burden on healthcare systems, and contributing to global health security. Moreover, vaccines offer individual protection, promote herd immunity, and are considered a cost-effective healthcare intervention.

Saudi Arabia Vaccine Market Trends:

The implementation of various policies and initiatives by the government to provide comprehensive, high-quality healthcare services to citizens and residents is creating a positive outlook for the market growth. Moreover, the rising inclusion of vaccines in the national healthcare plan, ensuring accessibility and affordability, is favoring the market growth. Along with this, the increasing focus on a strategic framework aimed at reducing the country’s dependence on oil and developing public service sectors, such as health, education, recreation, and tourism, is positively influencing the market growth. Additionally, the introduction of the national immunization program in the country, mandating vaccines against various diseases, is bolstering the market growth. In addition to this, the increasing awareness among the population about the importance of vaccines due to the widespread organization of educational campaigns and easy access to healthcare facilities is supporting the market growth. Furthermore, rapid technological advancements in vaccine development, such as messenger ribonucleic acid (mRNA) vaccine platforms, opening new avenues for rapid and effective vaccine design, are anticipated to drive the market growth. In line with this, the heightened popularity of e-health services and mobile applications to improve the management of vaccination schedules and records is acting as a growth-inducing factor. Apart from this, the geopolitical position and economic stability of Saudi Arabia, encouraging pharmaceutical companies to establish and expand their footprint, is positively impacting the market growth. Besides this, the growing collaborations between international vaccine manufacturers and local entities, boosting the availability of a wider range of vaccines, are providing an impetus to the market growth. Additionally, the growing pediatric population and rising life expectancy, prompting an increasing demand for vaccines, are favoring the market growth.

Saudi Arabia Vaccine Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user.

Product Type Insights:

Saudi Arabia Vaccine Market

  • Multivalent Vaccine
  • Monovalent Vaccine
     

The report has provided a detailed breakup and analysis of the market based on the product type. This includes multivalent vaccine and monovalent vaccine.

Treatment Type Insights:

  • Preventive Vaccine
  • Therapeutic Vaccine
     

A detailed breakup and analysis of the market based on the treatment type have also been provided in the report. This includes preventive vaccine and therapeutic vaccine.

Technology Insights:

  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the technology. This includes conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and others.

Route of Administration Insights:

  • Intramuscular and Subcutaneous Administration
  • Oral Administration
  • Others
     

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes intramuscular and subcutaneous administration, oral administration, and others.

Patient Type Insights:

  • Pediatric
  • Adult
     

The report has provided a detailed breakup and analysis of the market based on patient type. This includes pediatric and adult.

Indication Insights:

  • Bacterial Diseases
    • Meningococcal Disease
    • Pneumococcal Disease
    • Diphtheria/Tetanus/Pertussis (DPT)
    • Tuberculosis
    • Haemophilus Influenzae (Hib)
    • Typhoid
    • Others
  • Viral Diseases
    • Hepatitis
    • Influenza
    • Human Papillomavirus (HPV)
    • Measles/Mumps/Rubella (MMR)
    • Rotavirus
    • Herpes Zoster
    • Varicella
    • Japanese Encephalitis
    • Rubella
    • Polio
    • Rabies
    • Dengue
    • Others
       

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes bacterial diseases (meningococcal disease, pneumococcal disease, diphtheria/tetanus/pertussis (DPT), tuberculosis, haemophilus influenzae (Hib), typhoid, and others) and viral diseases (hepatitis, influenza, human papillomavirus (HPV), measles/mumps/rubella (MMR), rotavirus, herpes zoster, varicella, Japanese encephalitis, rubella, polio, rabies, dengue, and others).

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Sales
  • Others
     

The report has provided a detailed breakup and analysis of the market based on distribution channel. This includes hospital pharmacies, retail pharmacies, institutional sales, and others.

End User Insights:

  • Hospitals
  • Clinics
  • Vaccination Centers
  • Academic and Research Institutes
  • Others
     

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, clinics, vaccination centers, academic and research institutes, and others.

Regional Insights:

Saudi Arabia Vaccine Market by Region

  • Northern and Central Region
  • Western Region
  • Eastern Region
  • Southern Region
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern and Central Region, Western Region, Eastern Region, and Southern Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Saudi Arabia Vaccine Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Product Type
  • Treatment Type
  • Technology
  • Route of Administration
  • Patient Type
  • Indication
  • Distribution Channel
  • End User
  • Region
Product Types Covered Multivalent Vaccine, Monovalent Vaccine
Treatment Types Covered Preventive Vaccine, Therapeutic Vaccine
Technologies Covered Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Others
Route of Administrations Covered Intramuscular and Subcutaneous Administration, Oral Administration, Others
Patient Types Covered Pediatric, Adult
Indications Covered
  • Bacterial Diseases: Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis (DPT), Tuberculosis, Haemophilus Influenzae (Hib), Typhoid, Others
  • Viral Diseases: Hepatitis, Influenza, Human Papillomavirus (HPV), Measles/Mumps/Rubella (MMR), Rotavirus, Herpes Zoster, Varicella, Japanese Encephalitis, Rubella, Polio, Rabies, Dengue, Others
Distribution Channels Covered Hospital Pharmacies, Retail Pharmacies, Institutional Sales, Others
End Users Covered Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, Others
Regions Covered Northern and Central Region, Western Region, Eastern Region, Southern Region
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Saudi Arabia vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Saudi Arabia vaccine market?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of product type?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of treatment type?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of technology?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of route of administration?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of patient type?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of indication?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of distribution channel?
  • What is the breakup of the Saudi Arabia vaccine market on the basis of end user?
  • What are the various stages in the value chain of the Saudi Arabia vaccine market? 
  • What are the key driving factors and challenges in the Saudi Arabia vaccine?
  • What is the structure of the Saudi Arabia vaccine market and who are the key players?
  • What is the degree of competition in the Saudi Arabia vaccine market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Saudi Arabia vaccine market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Saudi Arabia vaccine market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Saudi Arabia vaccine industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Saudi Arabia Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARATI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More
DEinternational Egypt

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

Read More